Dual Targeting of ErbB2 and MUC1 in Breast Cancer Using Chimeric Antigen Receptors Engineered to Provide Complementary Signaling

Scott Wilkie(King's College London), May CI van Schalkwyk(King's College London), Steve Hobbs(Cancer Research UK), David M. Davies(Kings Health Partners), Sjoukje J. C. van der Stegen(Guy's Hospital), Ana C. Parente Pereira(Guy's Hospital), S. Burbridge(Kings Health Partners), Carol Box(Cancer Research UK), Suzanne A. Eccles(Institute of Cancer Research), John Maher(King's College London)
Journal of Clinical Immunology
April 16, 2012
Cited by 483

Abstract


Related Papers

No related papers found

Powered by citation graph analysis